Putrajaya paid a premium price for certain Sinovac Covid-19 vaccinations owing to a critical need caused by Pharmaniaga’s late delivery of vaccines in April and May of this year, according to the Public Accounts Committee (PAC).
Government Found To Have Paid Premium Prices For Sinovac Vaccines Due To Pharmaniaga Delay Says PAC
According to the Public Accounts Committee (PAC), Putrajaya paid a premium price for certain Sinovac Covid-19 vaccinations owing to a critical need caused by Pharmaniaga’s late delivery of vaccines in April and May of this year.
This was one of the PAC’s conclusions in its report, released today, on the acquisition and use of Covid-19 vaccine by the Science, Technology, and Innovation Ministry, the Health Ministry, and the Finance Ministry for Malaysian citizens.
source - fmt
“The PAC is satisfied that the procurement prices for the vaccines from various portfolios paid for by the government were reasonable.
“However, the PAC found that the government had to pay a premium price – an increase between 16.78 to 18.12 percent – for the purchase of some of the finished Sinovac vaccines.
“(Among the reasons for this was) due to Pharmaniaga’s delay in delivering (finished vaccines) in April, May, and June 2021 and also due to the pressing need at the time.
“PAC is of the opinion that the government should stick to the same price as agreed to in the earlier deal,” the committee stated in its summary of the report.
During the early part of this year, the country faced a crisis owing to rapidly increasing Covid-19 infections and a stalled vaccine rollout due to delayed vaccine delivery.
Following enhanced vaccine delivery from manufacturers in July, the vaccination rate climbed significantly.
Pharmaniaga earlier agreed to acquire a “ready-to-fill" bulk product of Sinovac’s vaccine, with the latter filling and completing the process of producing individual vaccination doses.